


Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist
Most Trending
-7.77%
+4.62%
-0.94%
-17.98%
INSP
Inspire Medical
$86.78
Strengths

Earnings are forecast to grow

Upgraded on attractively valued

Outperform the market

Expands stock buyback program
Chart
$78.84 (+10.07%)
$88.34 (-1.77%)
$130.91 (-33.71%)
$188.67 (-54.00%)
INSP has Moderate risk level based on volatility, sector strength, volume, investor confidence, and outlook.
Click here to check what is your level of risk
Risks Indicators

Beta greater than 1.0

INSP overall standing based on key factors, offering insights into analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Above analyst estimates
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum

Price value has negative momentum
Activity
Activity

Expands stock buyback program
Future
Future

Earnings are forecast to grow

Outperform the market
![]()
INSP Analysts opinion is positive and also has improved from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
INSP Street Sentiment is extremely bullish and have positive views on the near-term outlook
What is INSP current stock price?
What are INSP stock strengths?
What risks are associated with INSP stock?
When is INSP next earnings report?
What is INSP market cap and volume?
What is INSP's current Stock IQ?
Should I buy INSP stock right now?
Is INSP a Strong Buy right now?
What does a 'Strong Buy' rating mean for INSP?
What does a 'Strong Sell' rating mean for INSP?
What factors influence INSP's Stock IQ?
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
-7.77%
+4.62%
-0.94%
-17.98%
INSP
Inspire Medical
Current Price
$86.78
Stock Insights
Strengths

Earnings are forecast to grow

Upgraded on attractively valued

Outperform the market

Expands stock buyback program

Chart
$78.84 (+10.07%)
$88.34 (-1.77%)
$130.91 (-33.71%)
$188.67 (-54.00%)
INSP Analysts Opinion
INSP Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings

Above analyst estimates
Rating
Rating

Upgraded on attractively valued
Momentum
Momentum

Price value has negative momentum
Activity
Activity

Expands stock buyback program
Future
Future

Earnings are forecast to grow

Outperform the market
![]()
INSP Analysts opinion is positive and also has improved from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
INSP Street Sentiment is extremely bullish and have positive views on the near-term outlook
INSP has Moderate risk level based on volatility, sector strength, volume, investor confidence, and outlook.
Click here to check what is your level of risk
Risks Indicators

Beta greater than 1.0

INSP Latest Analysis
Wells Fargo Upgrades Inspire Medical Systems (INSP). Fintel reports that on November 4 2025 Wells Fargo upgraded their outlook for Inspire Medical Systems (NYSE:INSP) from Equal-Weight to Overweight. Analyst Price Forecast Suggests 72.47% Upside
Tue Nov 4, 2025
INSP Stock Gains Following Q3 Earnings Beat Gross Margin Expands. Inspire Medical tops third-quarter 2025 estimates as revenue climbs and gross margin improves with full-year EPS guidance raised.
Tue Nov 4, 2025
These Analysts Cut Their Forecasts On Inspire Medical Systems Following Q3 Results. INSP) reported better-than-expected third-quarter financial results and raised its FY25 GAAP EPS results above estimates on Monday.Inspire Medical Systems reported quarterly earnings of 38 cents per share which beat the analyst consensus estimate of a loss of 19 cents per share. The company reported quarterly sales of $224.501 million which beat the analyst consensus estimate of $220.467 million.Inspire Medical S
Tue Nov 4, 2025
Inspire Medical Systems signals 10–11% revenue growth for 2026 while reaffirming $900M–$910M guidance for 2025.
Tue Nov 4, 2025
Inspire Medical stock rating upgraded by Wells Fargo despite price target cut.
Tue Nov 4, 2025
Inspire Medical cut at Jefferies on GLP-1 uptake potential rivalry.
Fri Oct 24, 2025
Analyst Expectations For Inspire Medical Systemss Future. 15 analysts have shared their evaluations of Inspire Medical Systems (NYSE:INSP) during the recent three months expressing a mix of ish and bearish perspectives.The table below summarizes their recent ratings showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.2490000100011000110022600The 12-month price targets analyzed by analysts offer insights with an average target of $129.2 a high est
Fri Oct 24, 2025
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
INSP Stock trends
INSP Stock performance
INSP Stock analysis
INSP investment strategies
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.